For: | Chen GX, Zheng LH, Liu SY, He XH. rAd-p53 enhances the sensitivity of human gastric cancer cells to chemotherapy. World J Gastroenterol 2011; 17(38): 4289-4297 [PMID: 22090785 DOI: 10.3748/wjg.v17.i38.4289] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i38/4289.htm |
Number | Citing Articles |
1 |
Hangjun Gong, Yu Cao, Gang Han, Yun Zhang, Qing You, Yidong Wang, Yamin Pan. p53/microRNA-374b/AKT1 regulates colorectal cancer cell apoptosis in response to DNA damage. International Journal of Oncology 2017; 50(5): 1785 doi: 10.3892/ijo.2017.3922
|
2 |
Diana Costa, Artur J. M. Valente, João Queiroz. Hydrogels. Gels Horizons: From Science to Smart Materials 2018; : 339 doi: 10.1007/978-981-10-6077-9_13
|
3 |
Renzhi Yu, Minghuan Wang, Xiuli Zhu, Zhe Sun, Aiying Jiang, Huixin Yao. Therapeutic effects of lenvatinib in combination with rAd‑p53 for the treatment of non‑small cell lung cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.9428
|
4 |
Junior A. Enow, Hummad I. Sheikh, Masmudur M. Rahman. Tumor Tropism of DNA Viruses for Oncolytic Virotherapy. Viruses 2023; 15(11): 2262 doi: 10.3390/v15112262
|
5 |
Qi Xie, Min-Yi Wu, Ding-Xuan Zhang, Yi-Ming Yang, Bao-Shuai Wang, Jing Zhang, Jin Xu, Wei-De Zhong, Jia-Ni Hu. Synergistic anticancer effect of exogenous wild-type <i>p53</i> gene combined with 5-FU in human colon cancer resistant to 5-FU <i>in vivo</i>. World Journal of Gastroenterology 2016; 22(32): 7342-7352 doi: 10.3748/wjg.v22.i32.7342
|
6 |
Diana Costa, Artur J.M. Valente, M. Graça Miguel, João Queiroz. Plasmid DNA hydrogels for biomedical applications. Advances in Colloid and Interface Science 2014; 205: 257 doi: 10.1016/j.cis.2013.08.002
|
7 |
Yong-Hua Xu, Shuo-Hui Liu, Fu-Rong Hao, Yin-Huan Zhang. Recombinant adenovirus p53 combined with radiotherapy improves efficacy and safety in the treatment of head and neck lymphoma. Cancer Biomarkers 2018; 23(2): 213 doi: 10.3233/CBM-181286
|
8 |
Li Qi, Guiqing Li, Peipei Li, Hongwei Wang, Xiaolong Fang, Tongchuan He, Jingjing Li. Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology. Genes & Diseases 2024; 11(4): 101155 doi: 10.1016/j.gendis.2023.101155
|
9 |
Jiawei Guo, Weiwei Yu, Hui Su, Xiufeng Pang. Genomic landscape of gastric cancer: molecular classification and potential targets. Science China Life Sciences 2017; 60(2): 126 doi: 10.1007/s11427-016-0034-1
|
10 |
Ling-yan Jiang, Meng Lian, Hong Wang, Ju-gao Fang, Qi Wang. Inhibitory effects of 5-Aza-2′-deoxycytidine and trichostatin A in combination with p53-expressing adenovirus on human laryngocarcinoma cells. Chinese Journal of Cancer Research 2012; 24(3): 232 doi: 10.1007/s11670-012-0232-6
|
11 |
Xiaoyong Fan, Hongzhen Lu, Youqiang Cui, Xianzeng Hou, Chuanjiang Huang, Guangcun Liu. Overexpression of p53 delivered using recombinant NDV induces apoptosis in glioma cells by regulating the apoptotic signaling pathway. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.5935
|
12 |
Sabino Russi, Henu Kumar Verma, Simona Laurino, Pellegrino Mazzone, Giovanni Storto, Anna Nardelli, Pietro Zoppoli, Giovanni Calice, Francesco La Rocca, Alessandro Sgambato, Valeria Lucci, Geppino Falco, Vitalba Ruggieri. Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells. International Journal of Molecular Sciences 2019; 20(15): 3736 doi: 10.3390/ijms20153736
|
13 |
Tuo Ruan, Weizhen Liu, Kaixiong Tao, Chuanqing Wu. <p>A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer</p>. OncoTargets and Therapy 2020; : 1797 doi: 10.2147/OTT.S239336
|
14 |
Jie Xiao, Jian Zhou, Min Fu, Li Liang, Qiaoling Deng, Xiaoyun Liu, Fumin Liu. Efficacy of recombinant human adenovirus-p53 combined with chemotherapy for locally advanced cervical cancer: A clinical trial. Oncology Letters 2017; 13(5): 3676 doi: 10.3892/ol.2017.5901
|
15 |
Hailong Zhang, Yixuan Hou, Liyun Xu, Zongyue Zeng, Siyang Wen, Yan-e Du, Kexin Sun, Jiali Yin, Lei Lang, Xiaoli Tang, Manran Liu. Cytoplasmic Drosha Is Aberrant in Precancerous Lesions of Gastric Carcinoma and Its Loss Predicts Worse Outcome for Gastric Cancer Patients. Digestive Diseases and Sciences 2016; 61(4): 1080 doi: 10.1007/s10620-015-3986-0
|
16 |
Hai‑Bo Qiao, Jia Li, Lian‑Jie Lv, Ben‑Jin Nie, Peng Lu, Feng Xue, Zhi‑Ming Zhang. The effects of interleukin 2 and rAd-p53 as a treatment for glioblastoma. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8408
|
17 |
Wei-Wei Zhang, Longjiang Li, Dinggang Li, Jiliang Liu, Xiuqin Li, Wei Li, Xiaolong Xu, Michael J. Zhang, Lois A. Chandler, Hong Lin, Aiguo Hu, Wei Xu, Dominic Man-Kit Lam. The First Approved Gene Therapy Product for Cancer Ad-p53(Gendicine): 12 Years in the Clinic. Human Gene Therapy 2018; 29(2): 160 doi: 10.1089/hum.2017.218
|
18 |
Anais Blanchet, Agathe Bourgmayer, Jean-Emmanuel Kurtz, Georg Mellitzer, Christian Gaiddon. Isoforms of the p53 Family and Gastric Cancer: A Ménage à Trois for an Unfinished Affair. Cancers 2021; 13(4): 916 doi: 10.3390/cancers13040916
|
19 |
Diana Costa, Artur J.M. Valente, João Queiroz. Handbook of Polymers for Pharmaceutical Technologies. 2015; : 145 doi: 10.1002/9781119041559.ch6
|
20 |
Henu Kumar Verma, Geppino Falco, L. V. K. S. Bhaskar. Theranostics Approaches to Gastric and Colon Cancer. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 117 doi: 10.1007/978-981-15-2017-4_8
|
21 |
Shao Wen Xiao, Yi-Zhi Xu, Bu-Fan Xiao, Jing Jiang, Chang-Qing Liu, Zhi-wei Fang, Dong-Ming Li, Xiao Fan Li, Yong Cai, Yong Heng Li, Yan Sun, Xing Su, Guang-Ying Zhu, Shan Wen Zhang. Recombinant Adenovirus-p53 Gene Therapy for Advanced Unresectable Soft-Tissue Sarcomas. Human Gene Therapy 2018; 29(6): 699 doi: 10.1089/hum.2017.103
|